GlassScriptPhysician profile
Ajayram Ullal
NPI 1003233933
$494.62
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $167 · 2024: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $216.36 | 2019-2024 | |
| Amgen INC. | $126.64 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $33.37 | 2019-2020 | |
| Medtronic Vascular, INC. | $27.69 | 2020 | |
| Abbott Laboratories | $24.73 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.72 | 2019 | |
| Pfizer INC. | $22.15 | 2020 | |
| Alnylam Pharmaceuticals INC. | $19.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajayram Ullal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.